Synthesis, Spectroscopic Characterization, and Biological Activities of Metal Complexes of 4-((4-Chlorophenyl)diazenyl)-2-((p-tolylimino)methyl)phenol

Table 8

The in vitro antimicrobial activity of [CDTMP] and its metal(II) complexes*.

Compound	Concentration (μgmL^−1)	Zone of inhibition (in mm)
		E. coli	S. aureus	P.  aeruginosa	A. niger	C.  albicans
CDTMP (𝐋𝟏)	5	9	9	10	R	8
	10	13	10	12	9	12
	15	10	12	R	11	9
[VO(CDTMP)2] (𝐋𝟏𝟏 )	5	16	R	14	15	16
	10	19	20	19	20	19
	15	25	27	22	26	27
[Mn(CDTMP)2·2H2O] (𝐋𝟏𝟐 )	5	8	10	18	9	R
	10	14	21	R	11	R
	15	R	R	11	R	R
[Co(CDTMP)2·2H2O] (𝐋𝟏𝟑 )	5	R	18	16	10	11
	10	19	25	24	12	18
	15	24	29	27	21	23
[Ni(CDTMP)2·2H2O] (𝐋𝟏𝟒 )	5	R	12	R	14	11
	10	17	21	17	17	14
	15	10	24	24	25	20
[Cu(CDTMP)2] (𝐋𝟏𝟓 )	5	21	20	21	20	23
	10	26	31	23	31	25
	15	27	33	26	32	29
[Zn(CDTMP)2·2H2O] (𝐋𝟏𝟔 )	5	7	5	7	7	5
	10	12	10	10	10	7
	15	15	20	15	12	15
Standard	5	5	5	5	2	2
	10	7	7	7	5	5
	15	9	9	9	7	7

Standard (Amikacin and Ketoconozole). *Zone of inhibition in mm. Each value observed is within the error limits of ±2. R: resistant.